Tuesday, April 15, 2014
Healthcare represents less than one per cent of the ASX, one of the world’s most dynamic growth sectors.
That’s why most Aussie healthcare stocks trade at what’s known as a ‘scarcity premium’.
Encompassing healthcare facilities, drug and biotechnology stocks, and medical equipment suppliers and manufacturers, the overall quality and performance of Australian healthcare stocks is impressive. Half of the top 10 achieved Skaffold’s preferred stock ratings of A1, A2, B1 and B2 based on their latest financial reports.
Despite a recent sell off, which has seen share prices of the top 10 fall, on average, 3% since late February, safety margins continue to be high, ranging between -15 and -75 per cent.
With the ‘scarcity premium’ enshrouding local healthcare stocks, we went in search of better healthcare value stocks offshore and found 6 standouts.
Monday, December 16, 2013
Investors who expected the recent avalanche of floats to offer up the best chance of a sequel to the 17.4% return the market delivered to 30 June and 21% year-on-year, have received a crude reminder. For a myriad reasons, none the least being overpriced and over spruiked companies wired to uninspiring sectors, most IPOs are best left alone.
The number of lack-lustre floats this year is a reminder that all IPOs need to be pressure-tested to ensure they’re both investment worthy and attractively priced. That’s especially true where listings are owned by private equity firms queuing up to exit and hedge funds that are also circling for a piece of the action.
Our four IPO tips will help you identify true quality and value within the mixed bag of floats coming up in 2014.
Monday, October 28, 2013
While Nine’s IPO offer documents are yet to be lodged, the market expects Nine’s float to proceed mid December. If the success of recent floats, including insurance broker Steadfast Group (SDF) and fertility clinic operator Virtus Health (VRT) are anything to go by, the timing of Nine’s float looks about as good as it gets.
Nine’s metropolitan free-to-air TV advertising market rose just above 9% in July which, due largely to election advertising, delivered the best monthly performance in three years. Nine’s share of the market rose 11.6% in July from a year ago to 37.7%, in part due to the Ashes cricket series, which helped it win market share from (number three-ranked) rival Ten Network.
Due to its prominence as a household brand, the Nine float will capture broad investors interest. Due to its sheer size some fund managers will be unable to ignore it.
If you’re serious about participating in the Nine IPO, we’ve put together a checklist of the float details need to pay specific attention to.
Monday, September 23, 2013
Inspired by the success of the recent float of fertility clinic operator Virtus Health (VRT), another dozen floats worth around $3.7 billion are expected to come to market between now and year’s end. If the calibre of companies in the float pipeline is anything to go by, this offers you a rare ground-floor entry into quality stocks on the cusp of a promising growth trajectory.
The share market has no shortage of IPOs that bombed, and relatively recent newcomers like Collins Foods (CKF) and Myer (MYR) have both struggled to trade above their float price.
To avoid future disasters you need to pressure-test your argument for IPOs against key performance criteria. Skaffold’s IPO tips should help you unearth the next Flight Centre (FLT) and avoid the buying the next Myer (MYR).